Stay updated on Apatinib Plus Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Apatinib Plus Pembrolizumab Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The APPEASE study record for apatinib combined with pembrolizumab is now displayed, with details on its design, participants, treatments, and measured outcomes. It also indicates that the trial was terminated before its Phase II portion because funding was withdrawn.
    Difference
    44%
    Check dated 2026-11-08T13:23:40.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T14:33:42.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces an NIH terminology transition, saying “Super Intelligence” is replacing “Artificial Intelligence” across NIH content. It appears above the study page’s 403 error message.
    Difference
    1%
    Check dated 2026-10-25T13:44:08.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.1 to v3.7.2; the page remains a 403 error screen.
    Difference
    0.2%
    Check dated 2026-10-18T14:11:25.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T13:47:31.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error indicating restricted access to the record. The new content includes the 403 header, a minimal HTML snippet declaring the error, a Home link, and a revision note.
    Difference
    18%
    Check dated 2026-09-20T15:43:22.000Z thumbnail image

Stay in the know with updates to Apatinib Plus Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.